HCPCS code Q5100 — Inj ustekinumab-kfce, 1 mg. Status: Active. Effective Jul 1, 2025. Source: CMS HCPCS Level II.

Q5100

Active

Inj ustekinumab-kfce, 1 mg

Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jul 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0869

MUE — Medically Unlikely Edits

Maximum units of Q5100 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 520
Outpatient Hospital 520
Practitioner Services 520

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
83257-0023-41 Yesintek
83257-0024-11 Yesintek
83257-0025-41 Yesintek
83257-0026-11 Yesintek

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2025-Q3
    Inj ustekinumab-kfce, 1 mg